Client News

mbiomics Announces Third Closing of Series A, Reaching €30 Million to Advance Microbiome Therapeutics

Proxygen Expands Platform Beyond Degradation to Build Next-Generation Induced Proximity Therapeutics

InflaRx Regains Compliance with Nasdaq Minimum Bid Price Requirement

AFYREN receives €3 million grant from the Grand Est Region through the European Just Transition Fund

CorTec’s Brain Interchange™ Accepted into FDA Total Product Life Cycle Advisory Program (TAP)

Formycon reports successful financial year 2025 with important operational progress, growing market presence and strategic partnerships

Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents

Ebenbuild publishes validation study in Nature Communications Medicine demonstrating strong predictive performance of lung digital twins

InflaRx Reports New Mechanistic Data for Izicopan Supporting its Potential as a Best-in-Class C5aR Inhibitor

Darwin AG to Present at Invest 2026 in Stuttgart and the Equity Forum in Frankfurt